Japan’s MHLW Gives Out 83 Pharmaceutical Merit Awards
This article was originally published in PharmAsia News
Japan’s Ministry of Health, Labor, and Welfare held its 2012 Merit Awards ceremony for achievements in pharmaceutical affairs Oct. 23, commending 83 individuals.
You may also be interested in...
The EU’s massive economic stimulus package, Next Generation EU, includes a wide-ranging health program that aims to make health systems more resilient to future threats by supporting the development and manufacture of affordable new medicines and vaccines as well as measures to prevent drug shortages.
The Swiss major focused almost exclusively on the benefits of the combination of Tecentriq and its TIGIT inhibitor tiragolumab at ASCO but also celebrated the approval of a Tecentriq/Avastin combo for hepatocellular carcinoma.
Mylan first announced plans to develop a biosimilar of the Botox cosmetic and therapeutic brands back in 2018 through an alliance with Revance Therapeutics. More than two years later, a verdict has been reached by the company.